Search Results 8461-8470 of 42451 for oral

  1. Beating the beast: Mayo Clinic's pediatric urologists and their sarcoma team's mission to cure rhabdomyosarcoma

    "When cancer cells spread beyond the primary tumor, standard intravenous or oral chemotherapy drugs won't be able to kill them," Dr. Gargollo says. "By ...

  2. Mouth cancer - Doctors and departments - Mayo Clinic

    Learn what healthcare professionals look for when diagnosing mouth cancer. Find out about oral cancer treatments, including surgery, chemotherapy and ...

  3. RAdiolabeled Perfusion To Identify Coronary Artery Disease Using WAter To Evaluate Responses Of Myocardial FLOW (RAPID-WATER-FLOW) - Mayo Clinic

    Participants who are on sildenafil (Viagra) or oral dipyridamole (Persantine, Aggrenox) therapy and for whom its use cannot be terminated or suspended for ≥ 24 ...

  4. Head and Neck Cancer Center - Doctors - Mayo Clinic

    outh care, Dental surgery, Oral appliance therapy, Cancer, Oral and throat cancer, Mouth cancer, Head and neck cancer, Facial deformity, Jaw tumors and ...

  5. Tongue cancer - Doctors and departments - Mayo Clinic

    Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating ...

  6. Safe Omission of Pelvic Lymph Node Dissection During Radical Prostatectomy - Mayo Clinic

    Patients that have had prior hormonal therapy such as Lupron or oral anti-androgens. Clinical oligometastatic disease with > 3 nodes positive on 18F-rhPSMA ...

  7. A Study to Detect Pancreatic Cancer Using Circulating Tumor Markers - Mayo Clinic

    Oral contrast given within 7 days of stool collection. Removal of more than 50% of colon or presence of ileostomy. Enteral feeds or TPN. Diagnosis of ...

  8. Mayo Clinic Q & A

    Mayo Clinic Q&A: Understanding surgical options for oral cancer featured image. Mayo Clinic Q&A: Understanding surgical options for oral cancer. Chloe Corey.

  9. FORTIFI-HN01: A Study Of Ficerafusp Alfa (BCA101) Or Placebo In Combination With Pembrolizumab In First-Line PD-L1-pos, R Or M HNSCC - Mayo Clinic

    Eligible primary tumor locations are oral cavity, hypopharynx, larynx or oropharynx (with documented HPV-negative disease if presenting with OPSCC). Note ...

  10. An Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized Formulation in Immunocompromised Subjects With Parainfluenza (PIV) Infection - Mayo Clinic

    Subjects currently treated with oral, aerosolized or IV ribavirin; Subjects taking any investigational drug used to research or treat PIV. Participating Mayo ...